HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nancy S Shulman Selected Research

danoprevir

1/2015DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4.
10/2013Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection.
11/2011Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients.
10/2010Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nancy S Shulman Research Topics

Disease

17Infections
02/2019 - 07/2005
7Fibrosis (Cirrhosis)
10/2018 - 02/2016
5Chronic Hepatitis C
01/2019 - 10/2010
2Chronic Renal Insufficiency
02/2019 - 06/2016
2Coinfection
01/2018 - 01/2017
2Hepatitis C
01/2018 - 11/2011
1Kidney Diseases (Kidney Disease)
02/2019
1Anemia
06/2016
1Chronic Kidney Failure (Chronic Renal Failure)
06/2016
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2013
1Acquired Immunodeficiency Syndrome (AIDS)
10/2002

Drug/Important Bio-Agent (IBA)

12Ribavirin (Virazole)FDA LinkGeneric
02/2019 - 04/2012
9Ritonavir (Norvir)FDA Link
02/2019 - 11/2011
8Antiviral Agents (Antivirals)IBA
01/2019 - 07/2005
7paritaprevirIBA
02/2019 - 02/2016
7dasabuvirIBA
02/2019 - 02/2016
7ombitasvirIBA
02/2019 - 02/2016
7InterferonsIBA
01/2019 - 10/2010
4danoprevirIBA
01/2015 - 10/2010
2glecaprevir and pibrentasvirIBA
10/2018 - 01/2018
2SofosbuvirIBA
10/2018 - 01/2018
2Darunavir (Prezista)FDA Link
01/2017 - 01/2017
2Protease Inhibitors (Protease Inhibitor)IBA
10/2013 - 10/2010
2NucleosidesIBA
10/2010 - 03/2007
1glecaprevirIBA
01/2018
1pibrentasvirIBA
01/2018
1Raltegravir PotassiumFDA Link
01/2017
1Atazanavir Sulfate (Reyataz)FDA Link
01/2017
1dolutegravirIBA
01/2017
1RNA (Ribonucleic Acid)IBA
01/2017
1ErythropoietinFDA Link
06/2016
1peginterferon alfa-2a (Pegasys)FDA Link
10/2013
1Alanine Transaminase (SGPT)IBA
10/2013
1MaravirocFDA Link
06/2013
1Interferon LambdaIBA
04/2012
1InterleukinsIBA
04/2012
12'- fluoro- 2'- methyl- 3',5'- diisobutyryldeoxycytidineIBA
10/2010
1Reverse Transcriptase InhibitorsIBA
03/2007
1Lamivudine (Epivir)FDA Link
07/2005
1Stavudine (Zerit)FDA LinkGeneric
10/2002
1Zidovudine (Retrovir)FDA LinkGeneric
10/2002

Therapy/Procedure

7Therapeutics
01/2019 - 10/2002
1Aftercare (After-Treatment)
01/2018
1Renal Dialysis (Hemodialysis)
06/2016
1Salvage Therapy
07/2005